Format
Sort by
Items per page

Send to

Choose Destination

Best matches for "blind psychiatrist" OR "blind psychiatrists" OR "visually impaired psychiatrist" OR "visually impaired psychiatrists":

Burden and depression in primary caregivers of persons with visual impairment. Khare S et al. Indian J Ophthalmol. (2016)

Major depressive and anxiety disorders in visually impaired older adults. van der Aa HP et al. Invest Ophthalmol Vis Sci. (2015)

Suicides in Visually Impaired Persons: A Nation-Wide Register-Linked Study from Finland Based on Thirty Years of Data. Meyer-Rochow VB et al. PLoS One. (2015)

Search results

Items: 1 to 20 of 18252

  • Quoted phrase not found.
1.

Beneficial effects of Silexan on sleep are mediated by its anxiolytic effect.

Seifritz E, Schläfke S, Holsboer-Trachsler E.

J Psychiatr Res. 2019 Apr 17;115:69-74. doi: 10.1016/j.jpsychires.2019.04.013. [Epub ahead of print]

PMID:
31121394
2.

A comparison of denoising pipelines in high temporal resolution task-based functional magnetic resonance imaging data.

Mayer AR, Ling JM, Dodd AB, Shaff NA, Wertz CJ, Hanlon FM.

Hum Brain Mapp. 2019 May 22. doi: 10.1002/hbm.24635. [Epub ahead of print]

PMID:
31119818
3.

Personality disorder and functioning in major depressive disorder: a nested study within a randomized controlled trial.

Kavanagh BE, Williams LJ, Berk M, Turner A, Jackson HJ, Mohebbi M, Kanchanatawan B, Ashton MM, Ng CH, Maes M, Berk L, Malhi GS, Dowling N, Singh AB, Dean OM.

Braz J Psychiatry. 2019 May 16. pii: S1516-44462019005008104. doi: 10.1590/1516-4446-2018-0308. [Epub ahead of print]

4.

A Web-Based Cognitive Behavior Therapy Intervention to Improve Social and Occupational Functioning in Adults With Type 2 Diabetes (The SpringboarD Trial): Randomized Controlled Trial.

Clarke J, Sanatkar S, Baldwin PA, Fletcher S, Gunn J, Wilhelm K, Campbell L, Zwar N, Harris M, Lapsley H, Hadzi-Pavlovic D, Christensen H, Proudfoot J.

J Med Internet Res. 2019 May 21;21(5):e12246. doi: 10.2196/12246.

5.

Effectiveness of Cognitive Behavioral Therapy and Eye Movement Desensitization and Reprocessing in Child Victims of Domestic Violence.

Jaberghaderi N, Rezaei M, Kolivand M, Shokoohi A.

Iran J Psychiatry. 2019 Jan;14(1):67-75.

PMID:
31114620
7.

Sodium benzoate for the treatment of behavioral and psychological symptoms of dementia (BPSD): A randomized, double-blind, placebo-controlled, 6-week trial.

Lin CH, Chen PK, Wang SH, Lane HY.

J Psychopharmacol. 2019 May 22:269881119849815. doi: 10.1177/0269881119849815. [Epub ahead of print]

PMID:
31113277
8.

Size matters: the importance of particle size in a newly developed injectable formulation for the treatment of schizophrenia.

Jain R, Meyer J, Wehr A, Rege B, von Moltke L, Weiden PJ.

CNS Spectr. 2019 May 21:1-8. doi: 10.1017/S1092852919000816. [Epub ahead of print]

PMID:
31111801
9.

Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depression: protocol for a systematic review and networkmeta-analysis.

Shinohara K, Efthimiou O, Ostinelli EG, Tomlinson A, Geddes JR, Nierenberg AA, Ruhe HG, Furukawa TA, Cipriani A.

BMJ Open. 2019 May 19;9(5):e027574. doi: 10.1136/bmjopen-2018-027574.

10.

Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.

Popova V, Daly EJ, Trivedi M, Cooper K, Lane R, Lim P, Mazzucco C, Hough D, Thase ME, Shelton RC, Molero P, Vieta E, Bajbouj M, Manji H, Drevets WC, Singh JB.

Am J Psychiatry. 2019 May 21:appiajp201919020172. doi: 10.1176/appi.ajp.2019.19020172. [Epub ahead of print]

PMID:
31109201
11.

Continued Benefits of Methylphenidate in ADHD After 2 Years in Clinical Practice: A Randomized Placebo-Controlled Discontinuation Study.

Matthijssen AM, Dietrich A, Bierens M, Kleine Deters R, van de Loo-Neus GHH, van den Hoofdakker BJ, Buitelaar JK, Hoekstra PJ.

Am J Psychiatry. 2019 May 21:appiajp201918111296. doi: 10.1176/appi.ajp.2019.18111296. [Epub ahead of print]

PMID:
31109200
12.

Efficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled Trial.

Carmi L, Tendler A, Bystritsky A, Hollander E, Blumberger DM, Daskalakis J, Ward H, Lapidus K, Goodman W, Casuto L, Feifel D, Barnea-Ygael N, Roth Y, Zangen A, Zohar J.

Am J Psychiatry. 2019 May 21:appiajp201918101180. doi: 10.1176/appi.ajp.2019.18101180. [Epub ahead of print]

PMID:
31109199
13.

Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial.

Hurd YL, Spriggs S, Alishayev J, Winkel G, Gurgov K, Kudrich C, Oprescu AM, Salsitz E.

Am J Psychiatry. 2019 May 21:appiajp201918101191. doi: 10.1176/appi.ajp.2019.18101191. [Epub ahead of print]

PMID:
31109198
14.

Impact of Oxytocin on the neural correlates of fearful face processing in PTSD related to childhood Trauma.

Flanagan JC, Sippel LM, Santa Maria MMM, Hartwell KJ, Brady KT, Joseph JE.

Eur J Psychotraumatol. 2019 May 7;10(1):1606626. doi: 10.1080/20008198.2019.1606626. eCollection 2019.

15.

Anodal Transcranial Direct Current Stimulation Induces High Gamma-Band Activity in the Left Dorsolateral Prefrontal Cortex During a Working Memory Task: A Double-Blind, Randomized, Crossover Study.

Ikeda T, Takahashi T, Hiraishi H, Saito DN, Kikuchi M.

Front Hum Neurosci. 2019 Apr 24;13:136. doi: 10.3389/fnhum.2019.00136. eCollection 2019.

16.

Relative Cerebral Blood Transit Time Decline and Neurological Improvement in Patients After Internal Carotid Artery Stenting.

Szarmach A, Małkiewicz MA, Zdun-Ryżewska A, Halena G, Radkowski M, Dzierżanowski J, Chwojnicki K, Muc A, Damaszko T, Łyźniak P, Piskunowicz M, Szurowska E, Demkow U, Winklewski PJ.

Adv Exp Med Biol. 2019 May 17. doi: 10.1007/5584_2019_378. [Epub ahead of print]

PMID:
31098943
17.

Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.

Serfaty M, King M, Nazareth I, Moorey S, Aspden T, Tookman A, Mannix K, Gola A, Davis S, Wood J, Jones L.

Health Technol Assess. 2019 May;23(19):1-106. doi: 10.3310/hta23190.

18.

Quantitative facial expression analysis revealed the efficacy and time course of oxytocin in autism.

Owada K, Okada T, Munesue T, Kuroda M, Fujioka T, Uno Y, Matsumoto K, Kuwabara H, Mori D, Okamoto Y, Yoshimura Y, Kawakubo Y, Arioka Y, Kojima M, Yuhi T, Yassin W, Kushima I, Benner S, Ogawa N, Kawano N, Eriguchi Y, Uemura Y, Yamamoto M, Kano Y, Kasai K, Higashida H, Ozaki N, Kosaka H, Yamasue H.

Brain. 2019 May 16. pii: awz126. doi: 10.1093/brain/awz126. [Epub ahead of print]

PMID:
31096266
19.

The relationship of varenicline agonism of α4β2 nicotinic acetylcholine receptors and nicotine-induced dopamine release in nicotine dependent humans.

McCaul ME, Wand GS, Kuwabara H, Dannals RF, Wong D, Xu X.

Nicotine Tob Res. 2019 May 16. pii: ntz080. doi: 10.1093/ntr/ntz080. [Epub ahead of print]

PMID:
31096265
20.

Including the blind community in precision medicine research: findings from a national survey and recommendations.

Sabatello M, Blake LA, Chao A, Silverman A, Ovadia Mazzoni R, Zhang Y, Chen Y, Appelbaum PS.

Genet Med. 2019 May 16. doi: 10.1038/s41436-019-0533-y. [Epub ahead of print]

PMID:
31092907

Supplemental Content

Loading ...
Support Center